Newer approaches to the treatment of acne vulgaris

American Journal of Clinical Dermatology

Volumn 13, Issue 6, 2012, Pages 357-364

  Simonart, Thierry ^a  

^a NONE   (Belgium)

Author keywords

Acne vulgaris; Antibacterials; Azelaic acid; Benzoyl peroxide; Clindamycin; Complementary and alternative medicine; Dapsone; Isotretinoin; Laser therapy; Lauric acids; Oral contraceptives; Photochemotherapy; Resveratrol; Retinoids; Vaccines

Indexed keywords

ANTIBIOTIC AGENT; AZELAIC ACID; BENZOYL PEROXIDE; CLINDAMYCIN; COLLAGEN SPONGE; COSMETIC; DAPSONE; ERYTHROMYCIN; ISOTRETINOIN; LIPOSOME; RESVERATROL; RETINOID; SALICYLIC ACID; SULFACETAMIDE; TAURINE BROMAMINE; TETRACYCLINE; UNCLASSIFIED DRUG; VACCINE;

ACNE VULGARIS; AEROSOL; ALTERNATIVE MEDICINE; ANTIBIOTIC THERAPY; ARTICLE; DIET; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; DRY SKIN; ERYTHEMA; HUMAN; LOW DRUG DOSE; MONOTHERAPY; NANOEMULSION; PRIORITY JOURNAL; PRURITUS; SKIN IRRITATION;

EID: 84867425051     PISSN: 11750561     EISSN: 11791888     Source Type: Journal    
DOI: 10.2165/11632500-000000000-00000     Document Type: Article

References (86)

1. Kim RH, Armstrong AW. Current state of acne treatment: Highlighting lasers, photodynamic therapy, and chemical peels. Dermatol Online J 2011 Mar; 17 (3): 2
2. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012 Jan 28; 379 (9813): 361-72
3. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: A community-based study. J Invest Dermatol 2009 Sep; 129 (9): 2136-41
4. Dre'no B. Recent data on epidemiology of acne [in French]. Ann Dermatol Venereol 2010 Nov; 137 Suppl. 2: S49-51
5. Gonçalves G, Amado J, Matos M, et al. The prevalence of acne among a group of Portuguese medical students. J Eur Acad Dermatol Venereol 2012 Apr; 26 (4): 514-7
6. Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: Prevalence across the life span. J Womens Health (Larchmt) 2012 Feb; 21 (2): 223-30
7. Golchai J, Khani SH, Heidarzadeh A, et al. Comparison of anxiety and depression in patients with acne vulgaris and healthy individuals. Indian J Dermatol 2010 Oct; 55 (4): 352-4
8. Dunn LK, O'Neill JL, Feldman SR. Acne in adolescents: quality of life, selfesteem, mood, and psychological disorders. Dermatol Online J 2011 Jan 15; 17 (1): 1
9. Gollnick H, Cunliffe W, Berson D, et al., Global Alliance to Improve Outcomes in Acne. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol 2003 Jul; 49 (1 Suppl.): S1-37
10. Strauss JS, Krowchuk DP, Leyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol 2007 Apr; 56 (4): 651-63
11. Dre'no B, Bettoli V, Ochsendorf F, et al. European recommendations on the use of oral antibiotics for acne. Eur J Dermatol 2004 Nov-Dec; 14 (6): 391-9
12. Nast A, Bayerl C, Borelli C, et al. S2k-guideline for therapy of acne [in German]. J Dtsch Dermatol Ges 2010 Jul; 8 Suppl. 2: S1-59
13. Thielitz A, Gollnick H. Topical retinoids in acne vulgaris: Update on efficacy and safety. Am J Clin Dermatol 2008; 9 (6): 369-81
14. Yentzer BA, McClain RW, Feldman SR. Do topical retinoids cause acne to ''flare''? J Drugs Dermatol 2009 Sep; 8 (9): 799-801
15. Gollnick HP, Finlay AY, Shear N. Can we define acne as a chronic disease? If so, how and when? Am J Clin Dermatol 2008; 9 (5): 279-84
16. Cunliffe WJ, Poncet M, Loesche C, et al. A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: A meta-analysis of five randomized trials. Br J Dermatol 1998 Oct; 139 Suppl. 52: 48-56
17. Eichenfield LF, WortzmanM. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: Efficacy in acne vulgaris patients aged 12 to 18 years. Pediatr Dermatol 2009 May-Jun; 26 (3): 257-61
18. Webster GF. Evidence-based review: Fixed-combination therapy and topical retinoids in the treatment of acne. J Drugs Dermatol 2011 Jun; 10 (6): 636-44
19. Eichenfield LF, Alió Sá enz AB. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: A phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study. J Drugs Dermatol 2011 Dec 1; 10 (12): 1382-96
20. Gold LS, Tan J, Cruz-Santana A, et al. A North American study of adapalenebenzoyl peroxide combination gel in the treatment of acne. Cutis 2009 Aug; 84 (2): 110-6
21. Lucky AW, Sugarman J. Comparison of micronized tretinoin gel 0.05% and tretinoin gel microsphere 0.1% in young adolescents with acne: A post hoc analysis of efficacy and tolerability data. Cutis 2011 Jun; 87 (6): 305-10
22. Torok HM, Pillai R. Safety and efficacy of micronized tretinoin gel (0.05%) in treating adolescent acne. J Drugs Dermatol 2011 Jun; 10 (6): 647-52
23. Castro GA, Oliveira CA, Mahecha GA, et al. Comedolytic effect and reduced skin irritation of a new formulation of all-trans retinoic acid-loaded solid lipid nanoparticles for topical treatment of acne. Arch Dermatol Res 2011 Sep; 303 (7): 513-20
24. Lee HE, Ko JY, Kim YH, et al. A double-blind randomized controlled comparison of APDDR-0901, a novel cosmeceutical formulation, and 0.1% adapalene gel in the treatment of mild-to-moderate acne vulgaris. Eur J Dermatol 2011 Nov-Dec; 21 (6): 959-65
25. Ganceviciene R, Zouboulis CC. Isotretinoin: State of the art treatment for acne vulgaris. J Dtsch Dermatol Ges 2010 Mar; 8 Suppl. 1: S47-59
26. Rigopoulos D, Larios G, Katsambas AD. The role of isotretinoin in acne therapy: Why not as first-line therapy? Facts and controversies. Clin Dermatol 2010 Jan-Feb; 28 (1): 24-30
27. Agarwal US, Besarwal RK, Bhola K. Oral isotretinoin in different dose regimens for acne vulgaris: A randomized comparative trial. Indian J Dermatol Venereol Leprol 2011 Nov-Dec; 77 (6): 688-94
28. Lee JW, Yoo KH, Park KY, et al. Effectiveness of conventional, low-dose and intermittent oral isotretinoin in the treatment of acne: A randomized, controlled comparative study. Br J Dermatol 2011 Jun; 164 (6): 1369-75
29. Bernstein CN, Nugent Z, Longobardi T, et al. Isotretinoin is not associated with inflammatory bowel disease: A population-based case-control study. Am J Gastroenterol 2009 Nov; 104 (11): 2774-8
30. Crockett SD, Porter CQ, Martin CF, et al. Isotretinoin use and the risk of inflammatory bowel disease: A case-control study. Am J Gastroenterol 2010 Sep; 105 (9): 1986-93
31. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: A systematic review. Semin Cutan Med Surg 2007 Dec; 26 (4): 210-20
32. Halvorsen JA, Stern RS, Dalgard F, et al. Suicidal ideation, mental health problems, and social impairment are increased in adolescents with acne: A population-based study. J Invest Dermatol 2011 Feb; 131 (2): 363-70
33. Langan SM, Batchelor JM. Acne, isotretinoin and suicide attempts: A critical appraisal. Br J Dermatol 2011 Jun; 164 (6): 1183-5
34. Sundström A, Alfredsson L, Sjö lin-Forsberg G, et al. Association of suicide attempts with acne and treatment with isotretinoin: Retrospective Swedish cohort study. BMJ 2010 Nov 11; 341: C5812
35. Lowenstein EB, Lowenstein EJ. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero. Clin Dermatol 2011 Nov-Dec; 29 (6): 652-61
36. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: Lessons from Europe. Br J Dermatol 2003 Mar; 148 (3): 467-78
37. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: Lessons from clinical studies. Br J Dermatol 2005 Aug; 153 (2): 395-403
38. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009 May; 60 (5 Suppl.): S1-50
39. Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: Randomised controlled trial. Lancet 2004 Dec 18-31; 364 (9452): 2188-95
40. Simonart T, Dramaix M, De Maertelaer V. Efficacy of tetracyclines in the treatment of acne vulgaris: A review. Br J Dermatol 2008 Feb; 158 (2): 208-16
41. Ochsendorf F. Minocycline in acne vulgaris: Benefits and risks. Am J Clin Dermatol 2010; 11 (5): 327-41
42. Skidmore R, Kovach R, Walker C, et al. Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne. Arch Dermatol 2003 Apr; 139 (4): 459-64
43. Toossi P, Farshchian M, Malekzad F, et al. Subantimicrobial-dose doxycycline in the treatment of moderate facial acne. J Drugs Dermatol 2008 Dec; 7 (12): 1149-52
44. Brandstetter AJ, Maibach HI. Topical dose justification: Benzoyl peroxide concentrations. J Dermatolog Treat. Epub 2011 Dec 27
45. Hughes BR, Norris JF, Cunliffe WJ. A double-blind evaluation of topical isotretinoin 0.05%, benzoyl peroxide gel 5%and placebo in patients with acne. Clin Exp Dermatol 1992 May; 17 (3): 165-8
46. Harper JC. Benzoyl peroxide development, pharmacology, formulation and clinical uses in topical fixed-combinations. J Drugs Dermatol 2010 May; 9 (5): 482-7
47. Choudhury S, Chatterjee S, Sarkar DK, et al. Efficacy and safety of topical nadifloxacin and benzoyl peroxide versus clindamycin and benzoyl peroxide in acne vulgaris: A randomized controlled trial. Indian J Pharmacol 2011 Nov; 43 (6): 628-31
48. Seidler EM, Kimball AB. Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne. J Am Acad Dermatol 2010 Jul; 63 (1): 52-62
49. Gollnick HP, Graupe K, Zaumseil RP. Azelaic acid 15%gel in the treatment of acne vulgaris: Combined results of two double-blind clinical comparative studies [in German]. J Dtsch Dermatol Ges 2004 Oct; 2 (10): 841-7
50. Stinco G, Bragadin G, Trotter D, et al. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. J Eur Acad Dermatol Venereol 2007 Mar; 21 (3): 320-5
51. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20%azelaic acid cream in the treatment of acne vulgaris: Comparison with vehicle and topical tretinoin. Acta Derm Venereol Suppl (Stockh) 1989; 143: 35-9
52. Stotland M, Shalita AR, Kissling RF. Dapsone 5% gel: A review of its efficacy and safety in the treatment of acne vulgaris. Am J Clin Dermatol 2009; 10 (4): 221-7
53. Pickert A, Raimer S. An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Expert Opin Pharmacother 2009 Jun; 10 (9): 1515-21
54. Kircik LH. Harnessing the anti-inflammatory effects of topical dapsone for management of acne. J Drugs Dermatol 2010 Jun; 9 (6): 667-71
55. Marcinkiewicz J, Wojas-Pelc A, Walczewska M, et al. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: A pilot study. Eur J Dermatol 2008 Jul-Aug; 18 (4): 433-9
56. Dre'no B, Fischer TC, Perosino E, et al. Expert opinion: Efficacy of superficial chemical peels in active acne management: What can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatol Venereol 2011 Jun; 25 (6): 695-704
57. Takenaka Y, Hayashi N, Takeda M, et al. Glycolic acid chemical peeling improves inflammatory acne eruptions through its inhibitory and bactericidal effects on Propionibacterium acnes. J Dermatol 2012 Apr; 39 (4): 350-4
58. Akarsu S, Fetil E, Yü cel F, et al. Efficacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris. J Dermatol 2012 May; 39 (5): 433-8
59. Del Rosso JQ. The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol 2009 Aug; 2 (8): 26-9
60. Fabbrocini G, Staibano S, De Rosa G, et al. Resveratrol-containing gel for the treatment of acne vulgaris: A single-blind, vehicle-controlled, pilot study. Am J Clin Dermatol 2011 Apr 1; 12 (2): 133-41
61. Arowojolu AO, Gallo MF, Lopez LM, et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2009 Jul 8; (3): CD004425
62. Guerra-Tapia A, Sancho Pe'rez B. Ethinylestradiol/chlormadinone acetate: Dermatological benefits. Am J Clin Dermatol 2011 Sep 6; 12 Suppl. 1: 3-11
63. Frangos JE, Alavian CN, Kimball AB. Acne and oral contraceptives: Update on women's health screening guidelines. J Am Acad Dermatol 2008 May; 58 (5): 781-6
64. Brown J, Farquhar C, Lee O, et al. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne. Cochrane Database Syst Rev 2009 Apr 15; (2): CD000194
65. Gribbon EM, Shoesmith JG, Cunliffe WJ, et al. The microaerophily and photosensitivity of Propionibacterium acnes. J Appl Bacteriol 1994 Nov; 77 (5): 583-90
66. Ross EV. Optical treatments for acne. Dermatol Ther 2005 May-Jun; 18 (3): 253-66
67. Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol 2000 May; 142 (5): 973-8
68. Tzung TY, Wu KH, Huang ML. Blue light phototherapy in the treatment of acne. Photodermatol Photoimmunol Photomed 2004 Oct; 20 (5): 266-9
69. Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol 2008 Mar; 22 (3): 267-78
70. Hamilton FL, Car J, Lyons C, et al. Laser and other light therapies for the treatment of acne vulgaris: Systematic review. Br J Dermatol 2009 Jun; 160 (6): 1273-85
71. Jih MH, Kimyai-Asadi A. Laser treatment of acne vulgaris. Semin Plast Surg 2007 Aug; 21 (3): 1 67-74
72. Gold MH, Biron J. Efficacy of a novel combination of pneumatic energy and broadband light for the treatment of acne. J Drugs Dermatol 2008 Jul; 7 (7): 639-42
73. Shamban AT, Enokibori M, Narurkar V, et al. Photopneumatic technology for the treatment of acne vulgaris. J Drugs Dermatol 2008 Feb; 7 (2): 139-45
74. Reuter J, Merfort I, Schempp CM. Botanicals in dermatology: An evidencebased review. Am J Clin Dermatol 2010; 11 (4): 247-67
75. Simonart T, Kabagabo C, De Maertelaer V. Homoeopathic remedies in dermatology: A systematic review of controlled clinical trials. Br J Dermatol 2011 Oct; 165 (4): 897-905
76. Magin PJ, Adams J, Pond CD, et al. Topical and oralCAMin acne: A review of the empirical evidence and a consideration of its context. Complement Ther Med 2006 Mar; 14 (1): 62-76
77. Simpson RC, Grindlay DJ, Williams HC. What's new in acne? An analysis of systematic reviews and clinically significant trials published in 2010-11. Clin Exp Dermatol 2011 Dec; 36 (8): 840-3
78. Koku Aksu AE, Metintas S, Saracoglu ZN, et al. Acne: Prevalence and relationship with dietary habits in Eskisehir, Turkey. J Eur Acad Dermatol Venereol. Epub 2011 Nov 10
79. Veith WB, Silverberg NB. The association of acne vulgaris with diet. Cutis 2011 Aug; 88 (2): 84-91
80. Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: A disease of Western civilization. Arch Dermatol 2002 Dec; 138 (12): 1584-90
81. Smith RN, Mann NJ, Braue A, et al. The effect of a high-protein, low glycemicload diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: A randomized, investigator-masked, controlled trial. J Am Acad Dermatol 2007 Aug; 57 (2): 247-56
82. Danby FW. Nutrition and acne. Clin Dermatol 2010 Nov-Dec; 28 (6): 598-604
83. Kim J. Acne vaccines: Therapeutic option for the treatment of acne vulgaris? J Invest Dermatol 2008 Oct; 128 (10): 2353-4
84. Rubinchik E, Dugourd D, Algara T, et al. Antimicrobial and antifungal activities of a novel cationic antimicrobial peptide, omiganan, in experimental skin colonisation models. Int J Antimicrob Agents 2009 Nov; 34 (5): 457-61
85. Wang Y, Zhang Z, Chen L, et al. Cathelicidin-BF, a snake cathelicidin-derived antimicrobial peptide, could be an excellent therapeutic agent for acne vulgaris. PLoS ONE 2011; 6 (7): E22120
86. Nakatsuji T, Kao MC, Fang JY, et al. Antimicrobial property of lauric acid against Propionibacterium acnes: Its therapeutic potential for inflammatory acne vulgaris. J Invest Dermatol 2009 Oct; 129 (10): 2480-8